Pharma

Your Article Summary

See Latest Articles

Salix Pharmaceuticals Reports 2Q2009 Results Updates Full Year Guidance
Salix Pharmaceuticals, 08/11/09

Salix Pharmaceuticals, Ltd. announced financial and operating results for the second quarter ended June 30, 2009. Total product revenue was $52.2 million for the second quarter of 2009, compared to $41.1 million for the second quarter of 2008. Total product revenue for the first six months of 2009 was $97.0 million compared to $75.3 million for the first six months of 2008. XIFAXAN® revenue for the second quarter of 2009 was $26.3 million, a 46% increase compared to the second quarter of 2008. XIFAXAN revenue for the first six months of 2009 was $50.4 million compared to $34.8 million for the first six months of 2008.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09

 See all of Financial Reports